Name
Roseni Hambakliinik OÜ
Registry code
12797742
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
10.02.2015 (9)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86231 - Provision of dental treatment
354 886 €
2 276 €
1%
2 772 €
(estimate is approximate)
94 612 €
5
Submitted
No tax arrears
2%
1%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Lõuna-Eesti Kliinik OÜ 12213675 | 50% - 1 250.00 EUR | - | - | |
| Antenor OÜ 11856520 | 50% - 1 250.00 EUR | - | - | |
| Aira Tokko 13.04.1965 (59) | - | Board member | - | |
| Indrek Truija 23.12.1963 (60) | - | - | Indirect ownership | Founder |
| Kristjan Rebane 30.04.1978 (46) | - | - | Indirect ownership |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| ArgoMed OÜ 12551053 | 100% - 2 502.00 EUR | - | - |
| 2019 30.06.2020 | 2020 29.06.2021 | 2021 16.06.2022 | 2022 29.06.2023 | 2023 16.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 183 505 € | 164 042 € | 222 220 € | 310 862 € | 354 886 € |
| Net profit (loss) for the period | 1 050 € | -6 235 € | 17 675 € | 41 040 € | 2 276 € |
| Profit Margin | 1% | -4% | 8% | 13% | 1% |
| Current Assets | 106 874 € | 106 300 € | 121 101 € | 111 406 € | 119 720 € |
| Fixed Assets | 12 989 € | 12 989 € | 11 693 € | 77 669 € | 68 885 € |
| Total Assets | 119 863 € | 119 289 € | 132 794 € | 189 075 € | 188 605 € |
| Current Liabilities | 26 257 € | 31 918 € | 31 748 € | 33 780 € | 38 094 € |
| Non Current Liabilities | 53 750 € | 53 750 € | 49 750 € | 62 959 € | 55 899 € |
| Total Liabilities | 80 007 € | 85 668 € | 81 498 € | 96 739 € | 93 993 € |
| Share Capital | - | - | - | - | - |
| Equity | 39 856 € | 33 621 € | 51 296 € | 92 336 € | 94 612 € |
| Employees | 4 | 4 | 5 | 4 | 5 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 19 922.39 € | 21 455.99 € | 6 |
| 2023 Q4 | - | 21 360.89 € | 22 966.8 € | 7 |
| 2023 Q3 | - | 23 212.63 € | 24 998.25 € | 6 |
| 2023 Q2 | - | 20 807.42 € | 22 367.14 € | 7 |
| 2023 Q1 | - | 16 931.97 € | 18 093.73 € | 6 |
| 2022 Q4 | - | 18 713.43 € | 20 225.93 € | 7 |
| 2022 Q3 | - | 18 189.57 € | 19 650.51 € | 7 |
| 2022 Q2 | - | 15 578.98 € | 16 829.29 € | 7 |
| 2022 Q1 | - | 20 746.92 € | 22 280.09 € | 7 |
| 2021 Q4 | - | 16 811.56 € | 17 963.39 € | 7 |
| 2021 Q3 | - | 11 701.54 € | 13 039.95 € | 7 |
| 2021 Q2 | - | 9 514.42 € | 10 278.29 € | 7 |
| 2021 Q1 | - | 14 429.55 € | 15 798.4 € | 8 |
| 2020 Q4 | - | 13 305.9 € | 14 313.96 € | 8 |
| 2020 Q3 | - | 13 328.39 € | 14 658.66 € | 7 |
| 2020 Q2 | - | 2 754.64 € | 2 754.64 € | 7 |
| 2020 Q1 | - | 11 342.75 € | 12 209.07 € | 8 |
